Amphastar Pharmaceuticals Statistics
Total Valuation
AMPH has a market cap or net worth of $1.94 billion. The enterprise value is $2.27 billion.
Market Cap | 1.94B |
Enterprise Value | 2.27B |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
Earnings Date | Aug 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
AMPH has 48.90 million shares outstanding. The number of shares has increased by 2.01% in one year.
Shares Outstanding | 48.90M |
Shares Change (YoY) | +2.01% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 22.01% |
Owned by Institutions (%) | 69.90% |
Float | 38.02M |
Valuation Ratios
The trailing PE ratio is 13.66 and the forward PE ratio is 10.44. AMPH's PEG ratio is 2.77.
PE Ratio | 13.66 |
Forward PE | 10.44 |
PS Ratio | 2.86 |
Forward PS | 2.40 |
PB Ratio | 2.88 |
P/FCF Ratio | 12.04 |
PEG Ratio | 2.77 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.13, with an EV/FCF ratio of 14.12.
EV / Earnings | 14.69 |
EV / Sales | 3.36 |
EV / EBITDA | 9.13 |
EV / EBIT | 10.36 |
EV / FCF | 14.12 |
Financial Position
The company has a current ratio of 2.18, with a Debt / Equity ratio of 0.93.
Current Ratio | 2.18 |
Quick Ratio | 1.69 |
Debt / Equity | 0.93 |
Debt / EBITDA | 2.52 |
Debt / FCF | 3.90 |
Interest Coverage | 6.20 |
Financial Efficiency
Return on equity (ROE) is 24.80% and return on invested capital (ROIC) is 13.70%.
Return on Equity (ROE) | 24.80% |
Return on Assets (ROA) | 10.30% |
Return on Capital (ROIC) | 13.70% |
Revenue Per Employee | $383,991 |
Profits Per Employee | $87,842 |
Employee Count | 1,761 |
Asset Turnover | 0.45 |
Inventory Turnover | 2.82 |
Taxes
In the past 12 months, AMPH has paid $29.21 million in taxes.
Income Tax | 29.21M |
Effective Tax Rate | 15.88% |
Stock Price Statistics
The stock price has decreased by -36.45% in the last 52 weeks. The beta is 0.80, so AMPH's price volatility has been lower than the market average.
Beta (5Y) | 0.80 |
52-Week Price Change | -36.45% |
50-Day Moving Average | 40.73 |
200-Day Moving Average | 47.82 |
Relative Strength Index (RSI) | 50.55 |
Average Volume (20 Days) | 412,216 |
Short Selling Information
The latest short interest is 4.17 million, so 8.52% of the outstanding shares have been sold short.
Short Interest | 4.17M |
Short Previous Month | 4.15M |
Short % of Shares Out | 8.52% |
Short % of Float | 10.96% |
Short Ratio (days to cover) | 12.09 |
Income Statement
In the last 12 months, AMPH had revenue of $676.21 million and earned $154.69 million in profits. Earnings per share was $2.90.
Revenue | 676.21M |
Gross Profit | 367.38M |
Operating Income | 211.56M |
Pretax Income | 183.90M |
Net Income | 154.69M |
EBITDA | 248.86M |
EBIT | 219.27M |
Earnings Per Share (EPS) | $2.90 |
Balance Sheet
The company has $291.99 million in cash and $627.12 million in debt, giving a net cash position of -$335.13 million or -$6.85 per share.
Cash & Cash Equivalents | 291.99M |
Total Debt | 627.12M |
Net Cash | -335.13M |
Net Cash Per Share | -$6.85 |
Equity (Book Value) | 672.36M |
Book Value Per Share | 13.75 |
Working Capital | 299.91M |
Cash Flow
In the last 12 months, operating cash flow was $198.41 million and capital expenditures -$37.48 million, giving a free cash flow of $160.93 million.
Operating Cash Flow | 198.41M |
Capital Expenditures | -37.48M |
Free Cash Flow | 160.93M |
FCF Per Share | $3.34 |
Margins
Gross margin is 54.33%, with operating and profit margins of 31.29% and 22.88%.
Gross Margin | 54.33% |
Operating Margin | 31.29% |
Pretax Margin | 27.20% |
Profit Margin | 22.88% |
EBITDA Margin | 36.80% |
EBIT Margin | 32.43% |
FCF Margin | 23.80% |
Dividends & Yields
AMPH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.01% |
Shareholder Yield | -2.01% |
Earnings Yield | 7.99% |
FCF Yield | 8.31% |
Analyst Forecast
The average price target for AMPH is $66.00, which is 66.63% higher than the current price. The consensus rating is "Buy".
Price Target | $66.00 |
Price Target Difference | 66.63% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | 15.88% |
EPS Growth Forecast (5Y) | 26.03% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
AMPH has an Altman Z-Score of 2.81 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.81 |
Piotroski F-Score | 5 |